Venture capital funding is drying up, but is this a crisis or an opportunity? Squire Servance, founder of Syridex Bio, explains the “denominator problem,” why savvy investors are targeting overlooked assets, and how his fund addresses health disparities.
💡 LINKS TO MORE CONTENT
Subscribe to my newsletter: https://lsg2g.substack.com/
Host: https://www.linkedin.com/in/christiansoschner/
Speaker: https://www.linkedin.com/in/squireservance/